Moreover, CD4+ T lymphocytes exhibited direct eradication ability of tumor cells by IL2 neutralization 36 which makes targeting CD4+ T lymphocytes a promising therapy for HL-related ICC. The gene discussed is CD4; the disease is neoplasm.